IHL incannex healthcare limited

Brisbane Meeting - Redomicile to USA, page-15

  1. 11 Posts.
    Resmed holds a large investment in Apnimed, developer of AD-109. There, Chief Medical Officer, Carlos Nunez, sits on Apnimed's scientific advisory board.AD109 is now entering phase 3 trials.


    Are we worried about this other product ? There trials have been conducted over a Large scale.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.